The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients with hepatocellular carcinoma (HCC) treated in the lenvatinib (LEN) and immunotherapy era (2018-2021) compared to the sorafenib (SOR) era (2008-2018).
 
Chloe Lim
No Relationships to Disclose
 
Carla Pires Amaro
No Relationships to Disclose
 
Philip Q. Ding
No Relationships to Disclose
 
Winson Y. Cheung
No Relationships to Disclose
 
Vincent C. Tam
Honoraria - Apobiologix; AstraZeneca; Eisai; Incyte; Ipsen; Roche Canada
Consulting or Advisory Role - Incyte; Ipsen; Roche Canada
Research Funding - AstraZeneca (Inst); Eisai (Inst); Exelixis (Inst); Ipsen (Inst); Merck (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - Amgen